Transplacental Transfer and Metabolism of Buprenorphine (original) (raw)

Aromatase Is the Major Enzyme Metabolizing Buprenorphine in Human Placenta

Sujal Deshmukh

Journal of Pharmacology and Experimental Therapeutics, 2003

View PDFchevron_right

Bidirectional transfer of methadone across human placenta

Sujal Deshmukh

Biochemical Pharmacology, 2005

View PDFchevron_right

Maternal buprenorphine treatment and infant outcome

Michelle Tuten

Drug and Alcohol Dependence, 2017

View PDFchevron_right

Methadone metabolism by human placenta

Sujal Deshmukh

Biochemical Pharmacology, 2004

View PDFchevron_right

Buprenorphine initiation to treat opioid use disorder in emergency rooms

Brian Fuehrlein

Journal of the Neurological Sciences, 2020

View PDFchevron_right

Buprenorphine Dosing for the Treatment of Opioid Use Disorder Through Pregnancy and Postpartum

Tamas Gal

Current Treatment Options in Psychiatry, 2020

View PDFchevron_right

Assessment of immunotoxicity of buprenorphine

Jan Willem van der Laan

Laboratory Animals, 1994

View PDFchevron_right

The history of the development of buprenorphine as an addiction therapeutic

Nancy Campbell

Annals of the New York Academy of Sciences, 2012

View PDFchevron_right

Maternal and Fetal Buprenorphine Pharmacokinetics in Pregnant Sheep During Transdermal Patch Dosing

Marko Lehtonen

European Journal of Pharmaceutical Sciences, 2021

View PDFchevron_right

Evaluation of an improved sustained-release buprenorphine formulation for use in mice

sherif Ibrahim

American Journal of Veterinary Research, 2014

View PDFchevron_right

Small doses of morphine enhance voluntary intake of a solution of only ethanol and water

Sandra Marglin

Bulletin of the psychonomic society, 1988

View PDFchevron_right

Maine Drug Death Report: January–June 2020

Marcella Sorg

2020

View PDFchevron_right

High dosage buprenorphine in primary care. A preliminary survey

Ánh Phó

European Neuropsychopharmacology, 1999

View PDFchevron_right

Maine Drug Death Report January–September 2020

Marcella Sorg

2020

View PDFchevron_right

Addiction pharmacogenetics

David Nielsen

Psychiatric Genetics, 2015

View PDFchevron_right

Expanded Maine Drug Death Report, 2018

Marcella Sorg

2019

View PDFchevron_right

Prenatal Buprenorphine/Naloxone or Methadone Use on Neonatal Outcomes in Michigan

Chaur-Dong Hsu

Cureus, 2022

View PDFchevron_right

Medications in Pregnancy and Lactation

Laura McKain

Obstetrics & Gynecology, 2009

View PDFchevron_right

Characterization of the pharmacokinetics of buprenorphine and norbuprenorphine in rats after intravenous bolus administration of buprenorphine

Tsang-Bin Tzeng

European Journal of Pharmaceutical Sciences, 2002

View PDFchevron_right

Transdermal Buprenorphine, Opioid Rotation to Sublingual Buprenorphine, and the Avoidance of Precipitated Withdrawal

Howard Kornfeld

American Journal of Therapeutics, 2015

View PDFchevron_right

Endogenous morphine

MASSIMO GUARNA

Trends in Neurosciences, 2000

View PDFchevron_right

Patterns of Drug-Related Mortality in Maine, 1997-2002

Marcella Sorg

DOAJ (DOAJ: Directory of Open Access Journals), 2003

View PDFchevron_right

30ièmes Journées Franco-Belges de Pharmacochimie

Jean-michel Bolla

Pharmaceuticals, 2016

View PDFchevron_right

Modelling buprenorphine reduction of fentanyl-induced respiratory depression

Geert Groeneveld

JCI Insight, 2022

View PDFchevron_right

Expanded Maine Drug Death Report for 2016

Marcella Sorg

2016

View PDFchevron_right

Patterns of Drug-induced Mortality in Maine, 2015 Update

Marcella Sorg

Maine Policy Review, 2016

View PDFchevron_right

First Quarter Maine Drug Death Report with Estimates for Second Quarter--January–March, 2020

Marcella Sorg

2020

View PDFchevron_right

Safety of intravenous methamphetamine administration during treatment with bupropion

John Roache

Psychopharmacology, 2005

View PDFchevron_right

Review of Prescribing Practices for Intermittent Bolus Administration of Morphine

Isabelle Gaboury

The Canadian Journal of Hospital Pharmacy, 2011

View PDFchevron_right

Intrathecal fentanyl with 0.5% bupivacaine heavy in chronic opium abusers

Sunil Katyal

Southern African Journal of Anaesthesia and Analgesia, 2012

View PDFchevron_right

Bidirectional translational research: Progress in understanding addictive diseases

David Nielsen

Neuropharmacology, 2009

View PDFchevron_right

Maine Drug-Related Mortality Patterns: 1997-2002

Marcella Sorg

PsycEXTRA Dataset, 2002

View PDFchevron_right

Opioid use disorder: current trends and potential treatments

Brian Fuehrlein

Frontiers in public health, 2024

View PDFchevron_right

Measuring morphine's capacity to establish a place preference

Sandra Marglin

Pharmacology, Biochemistry and Behavior, 1989

View PDFchevron_right

Pain and palliative medicine

Amos Bailey

The Journal of Rehabilitation Research and Development, 2007

View PDFchevron_right